ℹ️ Affiliate Disclosure: This page contains paid affiliate links. NerveSync Institute may earn a commission if you purchase through our links, at no additional cost to you. This disclosure is made in accordance with FTC guidelines. Content is for informational and educational purposes only — not medical advice.
🧬
NerveSync Institute
Nerve Health & Wellness · Est. 2024
Free Assessment · 2 Minutes
🧪 Nerve Health Self-Assessment

Are Your Symptoms Signs of Peripheral Nerve Stress?

Answer 6 quick questions to receive your personalized nerve health profile and nutritional support recommendations.

✓ Takes under 2 minutes
✓ Personalized to your profile
✓ Based on published research

For informational and educational purposes only. Does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional.

Question 1 of 6 — Your Symptoms
What is your most bothersome nerve-related symptom?
Select the option that most closely matches your experience.
🔥
Burning or stabbing pain
Pain in feet, legs, or hands — often worse at night
⚡
Tingling or "pins and needles"
Electric or prickling sensations in extremities
🧊
Numbness or loss of sensation
Reduced feeling in toes, feet, fingers, or hands
😌
No noticeable symptoms yet
I'm here for preventive or general wellness purposes
Question 2 of 6 — Severity
How often do these symptoms affect your daily life?
Think about the past 3 months on average.
🌤️
Rarely — only occasionally noticeable
Symptoms appear from time to time but don't limit my activities
☁️
Sometimes — a few times per week
Noticeable and occasionally interferes with comfort or sleep
🌧️
Often — most days
Regularly affects my sleep, walking, or daily activities
⛈️
Constantly — nearly every day
Symptoms are persistent and significantly impact my quality of life
Question 3 of 6 — Location
Where do you experience these sensations most?
Select the area that's most affected.
🦶
Feet and/or toes
Most commonly the first area affected by peripheral neuropathy
🦵
Lower legs and calves
Symptoms that travel up from the feet
🤲
Hands and fingers
Tingling, weakness, or numbness in the upper extremities
🔄
Multiple areas / generalized
Symptoms in more than one location
Question 4 of 6 — Risk Factors
Which of the following applies to your health history?
This helps us identify which nutritional factors are most relevant to your profile.
🩸
Diabetes or pre-diabetes
High blood sugar is a common factor studied in relation to peripheral nerve health
💊
Long-term medication use
Including statins, metformin, or chemotherapy agents
🫀
Circulation or cardiovascular issues
Poor blood flow can deprive nerves of oxygen and nutrients
❓
No known cause identified
Symptoms appeared without a clear medical explanation (idiopathic)
Question 5 of 6 — Nighttime Symptoms
How do your symptoms affect your sleep?
Nighttime worsening is a hallmark pattern of peripheral neuropathy.
😴
Sleep is not affected
Symptoms don't disturb my rest
🌙
Mild disruption — I wake occasionally
Some nights are uncomfortable but I manage
😩
Significant disruption — frequent waking
Burning or tingling wakes me up multiple times
🥱
Severe — I barely sleep through the night
Pain and sensations make restful sleep very difficult
Question 6 of 6 — Your Profile
Which age group best describes you?
Nerve health needs — and the most relevant nutritional factors — differ significantly with age.
🌱
Under 50
Focus on foundational nerve protection and early support
🎯
50 – 64
Age range where peripheral neuropathy becomes increasingly common
🌟
65 – 74
Comprehensive nerve nutritional support is most relevant at this stage
👴
75 or older
Advanced nerve support addressing multiple nutritional factors simultaneously
Analyzing Your Nerve Health Profile…
Please wait while we review your responses
🔍
Reviewing symptom pattern & severity
🧬
Matching to published neuropathy research
📋
Generating your personalized profile
Your Nerve Health Risk Score
—
out of 14
—
—
📋 Your Personalized Profile

—

Nutritional Factors Relevant to Your Profile

⚠️ Please note: This assessment is for general informational purposes only and does not constitute a medical diagnosis or treatment recommendation. If you are experiencing persistent pain, numbness, or tingling, please consult a qualified healthcare professional for a proper evaluation. If you are pregnant, nursing, taking prescription medications, or have an existing medical condition, consult your physician before starting any supplement.

Nutritional Support Matched to Your Profile

NerveSync combines the key compounds studied for peripheral nerve health in a single daily formula for comprehensive nerve nutritional support.

Explore NerveSync Options → View 3-Bottle Supply

* Not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Always consult your healthcare provider before use.

Made in the USA  ·  GMP-Certified  ·  FDA-Registered Facility  ·  Secure Checkout via ClickBank

* These statements have not been evaluated by the FDA. NerveSync is not intended to diagnose, treat, cure, or prevent any disease. Individual results vary.

Scientific References

  1. Ang CD, et al. "Vitamin B for treating peripheral neuropathy." Cochrane Database Syst Rev. 2008;(3):CD004573. pubmed.ncbi.nlm.nih.gov/18646105
  2. Ziegler D, et al. "Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid." Diabetologia. 1995;38(12):1425–1433. pubmed.ncbi.nlm.nih.gov/8786016
  3. Mijnhout GS, et al. "Alpha lipoic acid for symptomatic peripheral neuropathy in patients with diabetes." J Int Med Res. 2012;40(2):401–408. pubmed.ncbi.nlm.nih.gov/22613397
  4. Didangelos T, et al. "Efficacy and safety of the combination of superoxide dismutase, alpha lipoic acid, vitamins E and C and folic acid in the management of peripheral neuropathy." Hormones (Athens). 2010;9(2):159–166. pubmed.ncbi.nlm.nih.gov/20555388
  5. Xu Q, et al. "Magnesium and peripheral nerve function." Magnes Res. 2013;26(1):10–18. pubmed.ncbi.nlm.nih.gov/23708888
  6. Sima AA. "Acetyl-L-carnitine in diabetic polyneuropathy: experimental and clinical data." CNS Drugs. 2007;21 Suppl 1:13–23. pubmed.ncbi.nlm.nih.gov/17696573